Authors:
OVERHOLT SM
LIU TJ
TAYLOR DL
WANG M
ELNAGGAR AK
SHILLITOE E
ADLERSTORTHZ K
STJOHN L
ZHANG WW
ROTH JA
CLAYMAN GL
Citation: Sm. Overholt et al., HEAD AND NECK SQUAMOUS-CELL GROWTH SUPPRESSION USING ADENOVIRUS-P53-FLAG - A POTENTIAL MARKER FOR GENE-THERAPY TRIALS, Clinical cancer research, 3(2), 1997, pp. 185-191
Citation: G. Dwivedi et al., TASTE-TEST BOOTH - AN INNOVATIVE TOOL IN HEALTH PROMOTION, Journal of the Canadian Dietetic Association, 58(2), 1997, pp. 90-93
Authors:
CHEN Z
KAMATH P
ZHANG S
STJOHN L
ADLERSTORTHZ K
SHILLITOE EJ
Citation: Z. Chen et al., EFFECTS ON TUMOR-CELLS OF RIBOZYMES THAT CLEAVE THE RNA TRANSCRIPTS OF HUMAN PAPILLOMAVIRUS TYPE-18, Cancer gene therapy, 3(1), 1996, pp. 18-23
Authors:
FRICK LW
LAMBE CU
STJOHN L
TAYLOR LC
NELSON DJ
Citation: Lw. Frick et al., PHARMACOKINETICS, ORAL BIOAVAILABILITY, AND METABOLISM IN MICE AND CYNOMOLGUS MONKEYS OF 5-FLUORO-1-[2-(HYDROXYMETHYL)-1,3-OXATHIOLAN-5-YL]CYTOSINE, AN AGENT ACTIVE AGAINST HUMAN-IMMUNODEFICIENCY-VIRUS AND HUMAN HEPATITIS-B VIRUS, Antimicrobial agents and chemotherapy, 38(12), 1994, pp. 2722-2729
Authors:
FRICK LW
STJOHN L
TAYLOR LC
PAINTER GR
FURMAN PA
LIOTTA DC
FURFINE ES
NELSON DJ
Citation: Lw. Frick et al., PHARMACOKINETICS, ORAL BIOAVAILABILITY, AND METABOLIC DISPOSITION IN RATS OF 5-FLUORO-1-[2-(HYDROXYMETHYL)-1,3-OXATHIOLAN-5-YL] CYTOSINE, ANUCLEOSIDE ANALOG ACTIVE AGAINST HUMAN-IMMUNODEFICIENCY-VIRUS AND HEPATITIS-B VIRUS, Antimicrobial agents and chemotherapy, 37(11), 1993, pp. 2285-2292